{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:23:52Z","timestamp":1792225432945,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12906-015-0938-3","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T08:58:09Z","timestamp":1448960289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)"],"prefix":"10.1186","volume":"15","author":[{"given":"Guo-Ying","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"938_CR1","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1183\/09031936.00007709","volume":"34","author":"A Pantosti","year":"2009","unstructured":"Pantosti A, Venditti M. What is MRSA? Eur Respir J. 2009;34:1190\u20136.","journal-title":"Eur Respir J"},{"key":"938_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","volume":"124","author":"MP Jevons","year":"1961","unstructured":"Jevons MP. \u201cCelbenin\u201d-resistant staphylococci. Br Med J. 1961;124:124\u20135.","journal-title":"Br Med J"},{"key":"938_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ijantimicag.2011.09.030","volume":"39","author":"S Stefani","year":"2012","unstructured":"Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H, et al. Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents. 2012;39:273\u201382.","journal-title":"Int J Antimicrob Agents"},{"key":"938_CR4","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJMoa025025","volume":"348","author":"S Chang","year":"2003","unstructured":"Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348:1342\u20137.","journal-title":"N Engl J Med"},{"key":"938_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.drup.2011.02.003","volume":"14","author":"L Freire-Moran","year":"2011","unstructured":"Freire-Moran L, Aronsson B, Manz C, Inge C, Gyssens IC, So AD, et al. Critical shortage of new antibiotics in development against multidrug-resistant bacteria\u2014Time to react is now. Drug Resist Update. 2011;14:118\u201324.","journal-title":"Drug Resist Update"},{"key":"938_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1039\/b212695h","volume":"21","author":"S Gibbons","year":"2004","unstructured":"Gibbons S. Anti-staphylococcal plant natural products. Nat Prod Rep. 2004;21:263\u201372.","journal-title":"Nat Prod Rep"},{"key":"938_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1055\/s-2008-1074518","volume":"74","author":"S Gibbons","year":"2008","unstructured":"Gibbons S. Phytochemicals for bacterial resistance \u2013 strengths, weaknesses and opportunities. Planta Med. 2008;74:594\u2013602.","journal-title":"Planta Med"},{"key":"938_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1039\/B916096E","volume":"27","author":"M Saleem","year":"2010","unstructured":"Saleem M, Nazir M, Ali MS, Hussain H, Lee YS, Riaz N, et al. Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep. 2010;27:238\u201354.","journal-title":"Nat Prod Rep"},{"key":"938_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.phymed.2008.06.008","volume":"15","author":"S Hemaiswarya","year":"2008","unstructured":"Hemaiswarya S, Kruthiventi AK, Doble M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine. 2008;15:639\u201352.","journal-title":"Phytomedicine"},{"key":"938_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.phymed.2008.12.018","volume":"16","author":"H Wagner","year":"2009","unstructured":"Wagner H, Ulrich-Merzenich G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16:97\u2013110.","journal-title":"Phytomedicine"},{"key":"938_CR11","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.3390\/molecules17032955","volume":"17","author":"GY Zuo","year":"2012","unstructured":"Zuo GY, Zhang XJ, Yang CX, Han J, Wang GC, Bian ZQ. Evaluation of traditional Chinese medicinal plants for anti-MRSA activity with reference to the treatment record of infectious diseases. Molecules. 2012;17:2955\u201367.","journal-title":"Molecules"},{"key":"938_CR12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.phymed.2014.03.004","volume":"21","author":"GY Zuo","year":"2014","unstructured":"Zuo GY, Han ZQ, Hao XY, Han J, Li ZS, Wang GC. Synergy of aminoglycoside antibiotics by 3-Benzylchroman derivatives from the Chinese drug Caesalpinia sappan against clinical methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine. 2014;21:936\u201341.","journal-title":"Phytomedicine"},{"key":"938_CR13","doi-asserted-by":"publisher","first-page":"8210","DOI":"10.3390\/ijms13078210","volume":"13","author":"GY Zuo","year":"2012","unstructured":"Zuo GY, An J, Han J, Zhang YL, Wang GC, Hao XY, et al. Isojacareubin from the Chinese herb Hypericum japonicum with antibacterial and antibiotic synergy effects on clinical methicillin-resistant Staphylococcus aureus (MRSA). Int J Mol Sci. 2012;13:8210\u20138.","journal-title":"Int J Mol Sci"},{"key":"938_CR14","first-page":"2282","volume-title":"Dictionary of Chinese crude drugs","author":"Nanjing University of Traditional Chinese Medicine (NUTCM)","year":"2005","unstructured":"Nanjing University of Traditional Chinese Medicine (NUTCM). Dictionary of Chinese crude drugs. 2nd ed. Shanghai, China: Shanghai Scientific Technologic Publisher; 2005. p. 2282\u20136.","edition":"2"},{"key":"938_CR15","first-page":"838","volume":"36","author":"SJ Zhang","year":"2013","unstructured":"Zhang SJ, Zhong LY. Advances in the chemical composition and modern pharmacological research of Magnolia officinalis. J Chin Med Materia. 2013;36:838\u201343.","journal-title":"J Chin Med Materia"},{"key":"938_CR16","first-page":"235","volume-title":"Chinese pharmacopoeia (I)","author":"Chinese Pharmacopoeia Commission","year":"2010","unstructured":"Chinese Pharmacopoeia Commission. Chinese pharmacopoeia (I). Beijing, China: Chemical Industry Press; 2010. p. 235."},{"key":"938_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.fitote.2011.11.020","volume":"83","author":"SX Yu","year":"2012","unstructured":"Yu SX, Yan RY, Liang RX, Wang W, Yang B. Bioactive polar compounds from stem bark of Magnolia officinalis. Fitoterapia. 2012;83:356\u201361.","journal-title":"Fitoterapia"},{"key":"938_CR18","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.3390\/molecules15096452","volume":"15","author":"J Shen","year":"2010","unstructured":"Shen J, Man K, Huang P, Chen W, Chen D, Cheng Y, et al. Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders. Molecules. 2010;15:6452\u201365.","journal-title":"Molecules"},{"key":"938_CR19","first-page":"5","volume":"2","author":"YS Liao","year":"1954","unstructured":"Liao YS. Studies on the antibacterial actions of Huang-lien and Hou-p\u2019o. Part I. The antibacterial actions of Huang-lien and Hou-p\u2019o in vitro. Acta Phamaceutica Sinica. 1954;2:5\u201310.","journal-title":"Acta Phamaceutica Sinica"},{"key":"938_CR20","first-page":"11","volume":"2","author":"YS Liao","year":"1954","unstructured":"Liao YS. Studies on the antibacterial actions of Huang-lien and Hou-p\u2019o. Part II. The anti-Bacillus anthracis action of Huang-lien and Hou-p\u2019o in Guinea pig. Acta Phamaceutica Sinica. 1954;2:11\u20136.","journal-title":"Acta Phamaceutica Sinica"},{"key":"938_CR21","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/jsfa.4280","volume":"91","author":"YJ Hu","year":"2011","unstructured":"Hu YJ, Qiao JL, Zhang X, Ge CR. Antimicrobial effect of Magnolia officinalis extract against Staphylococcus aureus. J Sci Food Agric. 2011;91:1050\u20136.","journal-title":"J Sci Food Agric"},{"key":"938_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1055\/s-2007-971412","volume":"44","author":"T Namba","year":"1982","unstructured":"Namba T, Tsunezuka M, Hattori M. Dental caries prevention by traditional Chinese medicines. Part II. Potent antibacterial action of Magnoliae cortex extracts against Streptococcus mutans. Planta Med. 1982;44:100\u20136.","journal-title":"Planta Med"},{"key":"938_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF02912226","volume":"8","author":"K Bae","year":"1985","unstructured":"Bae K, Yoo B, Lee M, Seo W. Antimicrobial activities of hydroxybiphenyl derivatives (I). Arch Pharm Res. 1985;8:85\u20139.","journal-title":"Arch Pharm Res"},{"key":"938_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF02899995","volume":"9","author":"W Seo","year":"1986","unstructured":"Seo W, Koo S, Bae K. Antimicrobial activities of hydroxybiphenyl derivatives (II). Arch Pharm Res. 1986;9:127\u201330.","journal-title":"Arch Pharm Res"},{"key":"938_CR25","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/0031-9422(91)83612-O","volume":"30","author":"JK Nitao","year":"1991","unstructured":"Nitao JK, Nair MG, Thorogoo DL, Johnson KSJ, Scriber M. Bioactive neolignans from the leaves of Magnolia virginiana. Phytochemistry. 1991;30:2193\u20135.","journal-title":"Phytochemistry"},{"key":"938_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1055\/s-2006-957453","volume":"64","author":"BS Chang","year":"1998","unstructured":"Chang BS, Lee YM, Ku Y, Bae KH, Chung CP. Antimicrobial activity of magnolol and honokiol against periodontopathic microorganisms. Planta Med. 1998;64:367\u20139.","journal-title":"Planta Med"},{"key":"938_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ptr.736","volume":"15","author":"K Ho","year":"2001","unstructured":"Ho K, Tsai C, Chen C, Huang J, Lin C. Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother Res. 2001;15:139\u201341.","journal-title":"Phytother Res"},{"key":"938_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejphar.2004.05.047","volume":"496","author":"J Park","year":"2004","unstructured":"Park J, Lee J, Jung E, Park Y, Kim K, Park B, et al. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Europ J Pharm. 2004;496:189\u201395.","journal-title":"Europ J Pharm"},{"key":"938_CR29","doi-asserted-by":"publisher","first-page":"9465","DOI":"10.1021\/jf072122h","volume":"55","author":"M Greenberg","year":"2007","unstructured":"Greenberg M, Urnezis P, Tian MM. Compressed mints and chewing gum containing Magnolia bark extract are effective against bacteria responsible for oral malodor. J Agric Food Chem. 2007;55:9465\u20139.","journal-title":"J Agric Food Chem"},{"key":"938_CR30","doi-asserted-by":"publisher","first-page":"11151","DOI":"10.1021\/jf8020859","volume":"56","author":"M Greenberg","year":"2008","unstructured":"Greenberg M, Dodds M, Minmin Tian MM. Naturally occurring phenolic antibacterial compounds show effectiveness against oral bacteria by a quantitative structure-activity relationship study. J Agric Food Chem. 2008;56:11151\u20136.","journal-title":"J Agric Food Chem"},{"key":"938_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12272-010-2225-7","volume":"33","author":"YS Kim","year":"2010","unstructured":"Kim YS, Lee JY, Park J, Hwang W, Lee J, Park D. Synthesis and microbiological evaluation of honokiol derivatives as new antimicrobial agents. Arch Pharm Res. 2010;33:61\u20135.","journal-title":"Arch Pharm Res"},{"key":"938_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF02990563","volume":"55","author":"M Mori","year":"1997","unstructured":"Mori M, Aoyama M, SDoi S. Antifungal constituents in the bark of Magnolia obovata Thunb. Holz als Roh-und Werkstoff. 1997;55:275\u20138.","journal-title":"Holz als Roh-und Werkstoff"},{"key":"938_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF02976465","volume":"23","author":"KH Bang","year":"2000","unstructured":"Bang KH, Kim YK, Min BS, Na MK, Rhee YH, Lee JP, et al. Antifungal activity of magnolol and honokiol. Arch Pharm Res. 2000;23:46\u20139.","journal-title":"Arch Pharm Res"},{"key":"938_CR34","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1111\/j.1365-2672.2009.04175.x","volume":"106","author":"NH Choi","year":"2009","unstructured":"Choi NH, Choi GJ, Min BS, Jang KS, Choi YH, Kang MS, et al. Effects of neolignans from the stem bark of Magnolia obovata on plant pathogenic fungi. J Appl Microb. 2009;106:2057\u201363.","journal-title":"J Appl Microb"},{"key":"938_CR35","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1016\/j.bmcl.2007.06.024","volume":"17","author":"F Amblard","year":"2007","unstructured":"Amblard F, Govindarajan B, Lefkove B, Rapp KL, Detorio M, Arbiser JL, et al. Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. Bioorg Med Chem Lett. 2007;17:4428\u201331.","journal-title":"Bioorg Med Chem Lett"},{"key":"938_CR36","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1439-0434.2008.01507.x","volume":"157","author":"GH Li","year":"2009","unstructured":"Li GH, Dang LI, Hong LJ, Zheng LJ, Liu FF, Li L, et al. Nematicidal activity of honokiol and magnolol isolated from Magnolia tripetala. J Phytopath. 2009;157:390\u20132.","journal-title":"J Phytopath"},{"key":"938_CR37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/cbdv.200490046","volume":"1","author":"WJ Syu","year":"2004","unstructured":"Syu WJ, Shen CC, Lu JJ, Lee GH, Sun CM. Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis. Chem Biodiversity. 2004;1:530\u20137.","journal-title":"Chem Biodiversity"},{"key":"938_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejmech.2011.12.039","volume":"51","author":"S Jada","year":"2012","unstructured":"Jada S, Reddy Doma M, Singh PP, Kumar S, Malik F, Sharma A, et al. Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds. Europ J Med Chem. 2012;51:35\u201341.","journal-title":"Europ J Med Chem"},{"key":"938_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1472-765X.2010.02900.x","volume":"51","author":"J Jin","year":"2010","unstructured":"Jin J, Guo N, Zhang J, Ding Y, Tang X, Liang J, et al. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans. Lett Appl Microbiol. 2010;51:351\u20137.","journal-title":"Lett Appl Microbiol"},{"key":"938_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF02857847","volume":"13","author":"K Bae","year":"1990","unstructured":"Bae K, Oh H. Synergistic effect of lysozyme on bactericidal activity of magnolol and honokiol against a cariogenic bacterium, Streptococcus mutans OMZ 176. Arch Pharm Res. 1990;13:117\u20139.","journal-title":"Arch Pharm Res"},{"key":"938_CR41","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1525-1438.2007.01070.x","volume":"18","author":"Y Liu","year":"2008","unstructured":"Liu Y, Chen L, He X, Fan L, Yang G, Chen X, et al. Enhancement of therapeutic effectiveness bycombining liposomal honokiol with cisplatin in ovarian carcinoma. Int J Gynecol Cancer. 2008;18:652\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"938_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2008.06.026","volume":"591","author":"H Liu","year":"2008","unstructured":"Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, K\u00fchnl A, et al. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Europ J Pharmacol. 2008;591:43\u201351.","journal-title":"Europ J Pharmacol"},{"key":"938_CR43","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/ptr.2472","volume":"22","author":"W Hou","year":"2008","unstructured":"Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, et al. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models. Phytother Res. 2008;22:1125\u201332.","journal-title":"Phytother Res"},{"key":"938_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021573","volume":"6","author":"S Arora","year":"2011","unstructured":"Arora S, Bhardwaj A, Srivastava SK, Singh S, McClellan S, Wang B, et al. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS ONE. 2011;6:e21573. doi: 10.1371\/journal.pone.0021573 .","journal-title":"PLoS ONE"},{"key":"938_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086369","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X, Beitler JJ, Wang H, Lee MJ, Huang W, Koenig L, et al. Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis. PLoS ONE. 2014;9:e86369. doi: 10.1371\/journal.pone.0086369 .","journal-title":"PLoS ONE"},{"key":"938_CR46","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2174\/156652412803833508","volume":"12","author":"S Arora","year":"2012","unstructured":"Arora S, Singh S, Piazza GA, Contreras CM, Panyam J, Singh AP. Honokiol: a novel natural agent for cancer prevention and therapy. Curr Mol Med. 2012;12:1244\u201352.","journal-title":"Curr Mol Med"},{"key":"938_CR47","unstructured":"Clinical Laboratory Standards Institute. Table 2C. Zone diameter and MIC interpretive standards for staphylococcus spp. In: Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Approved standard. Wayne, PA, USA: CLSI; 2012. p. M100\u2013S22."},{"key":"938_CR48","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1128\/JCM.43.10.5026-5033.2005","volume":"43","author":"K Zhang","year":"2005","unstructured":"Zhang K, McClure JA, Elsayed S, Louie T, Conly JM. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I toV in methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005;43:5026\u201333.","journal-title":"J Clin Microbiol"},{"key":"938_CR49","volume-title":"Performance standards for antimicrobial disk susceptibility tests. Approved standard, 9th ed. Document M2-A9","author":"Clinical Laboratory Standards Institute","year":"2006","unstructured":"Clinical Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Approved standard, 9th ed. Document M2-A9. Wayne, PA, USA: CLSI; 2006."},{"key":"938_CR50","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.micres.2007.02.012","volume":"164","author":"FZ Akcam","year":"2009","unstructured":"Akcam FZ, Tinaz GB, Kaya O, Tigli A, Ture E, Hosoglu S. Evaluation of methicillin resistance by cefoxitin disk diffusion and PBP2a latex agglutination test in mecA-positive Staphylococcus aureus, and comparison of mecA with femA, femB, femX positivities. Microbiol Res. 2009;164:400\u20133.","journal-title":"Microbiol Res"},{"key":"938_CR51","unstructured":"Clinical Laboratory Standards Institute. Approved standard M100-S17. PA, USA.: CLSI, Wayne; 2007. Performance Standards for Antimicrobial Susceptibility Testing-17th Informational Supplement."},{"key":"938_CR52","unstructured":"Clinical Laboratory Standards Institute. Approved standard M7-A7. PA, USA.: CLSI, Wayne; 2006. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 7th ed."},{"key":"938_CR53","volume-title":"Methods for determining bactericidal activity antimicrobial agents","author":"Clinical Laboratory Standards Institute","year":"1999","unstructured":"Clinical Laboratory Standards Institute. Methods for determining bactericidal activity antimicrobial agents. Wayne, PA, USA: Approved Guidelines. Document M26-A. CLSI (formerly NCCLS); 1999."},{"key":"938_CR54","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1128\/AAC.46.2.558-560.2002","volume":"46","author":"ZQ Hu","year":"2002","unstructured":"Hu ZQ, Zhao WH, Asano N, Yoda Y, Hara Y. Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46:558\u201360.","journal-title":"Antimicrob Agents Chemother"},{"key":"938_CR55","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1128\/JCM.43.1.140-143.2005","volume":"43","author":"G Orhan","year":"2005","unstructured":"Orhan G, Bayram A, Zer Y, Balci I. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol. 2005;43:140\u20133.","journal-title":"J Clin Microbiol"},{"key":"938_CR56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jac\/dkm457","volume":"61","author":"JN Chin","year":"2008","unstructured":"Chin JN, Jones RN, Sader HS, Savage PB, Rybak MJ. Potential synergy activity of the novel ceragenin, CAS-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. J Antimicrob Chemother. 2008;61:365\u201370.","journal-title":"J Antimicrob Chemother"},{"key":"938_CR57","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.4014\/jmb.0903.03015","volume":"19","author":"ES Kim","year":"2009","unstructured":"Kim ES, Jeong SI, Kim JH, Park C, Kim SM, Kim JK, et al. Synergistic effects of the combination of 20-hydroxyecdysone with ampicillin and gentamicin against methicillin-resistant Staphylococcus aureus. J Microbiol Biotechnol. 2009;19:1576\u201381.","journal-title":"J Microbiol Biotechnol"},{"key":"938_CR58","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1073\/pnas.79.21.6693","volume":"79","author":"SM Mates","year":"1982","unstructured":"Mates SM, Eisenberg ES, Mandel LJ, Patel L, Kaback HR, Miller MH. Membrane potential and gentamicin uptake in Staphylococcus aureus. Proc Natl Acad Sci U S A. 1982;79:6693\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"938_CR59","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1128\/AAC.00216-07","volume":"51","author":"ECJ Smith","year":"2007","unstructured":"Smith ECJ, Kaatz GW, Seo SM, Wareham N, Williamson EM, Gibbons S. The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Antimicro Agents Chemother. 2007;51:4480\u20133.","journal-title":"Antimicro Agents Chemother"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0938-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-015-0938-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0938-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T20:43:47Z","timestamp":1475527427000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-015-0938-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["938"],"URL":"https:\/\/doi.org\/10.1186\/s12906-015-0938-3","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"425"}}